Grifols (GRFS) Cash from Investing Activities (QoQ) (2010 - 2020)

Grifols (GRFS) Cash from Investing Activities (QoQ) (2010 - 2020) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Grifols	-	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2020	71.26%
Mar 31, 2019	-138.22%
Jun 30, 2018	-525.53%
Mar 31, 2018	-95.06%
Jun 30, 2017	-95.53%
Mar 31, 2017	1,746.63%
Dec 31, 2016	84.94%
Dec 31, 2015	-1,648.83%
Sep 30, 2015	-91.38%
Jun 30, 2015	315.70%
Mar 31, 2015	-525.92%
Dec 31, 2014	-97.12%
Sep 30, 2014	203.13%
Jun 30, 2014	-307.63%
Mar 31, 2014	1,686.56%
Dec 31, 2013	17.92%
Sep 30, 2013	41.03%
Jun 30, 2013	-24.22%
Mar 31, 2013	20.90%
Dec 31, 2012	262.96%